Recent approaches to periodontal therapy

Expert Opinion on Pharmacotherapy

Volumn 1, Issue 6, 2000, Pages 1219-1226

  Karpinia, Katherine ^a   Magnusson, Ingvar ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

Author keywords

Antimicrobial; Drug delivery systems; Growth factors; Periodontal disease; Regeneration

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFECT; ENZYMOLOGY; HUMAN; MICROBIOLOGY; PATHOLOGY; PERIODONTAL DISEASE; REGENERATION; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CLINICAL TRIALS; HUMANS; PERIODONTAL DISEASES; REGENERATION;

EID: 0034279674     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.1.6.1219     Document Type: Article

References (50)

1. RAMFJORD SP, KNOWLES JW, NISSLE RR et al.-. Longitudinal study of periodontal therapy./ Periodontol. (1973) 44:66-77.
2. LINDHE J, WESTFELT E, NYMAN S et al.: Healing following surgical/non-surgical treatment of periodontal disease. A Clinical study. J. Clin. Periodontol. (1982) 9:115-128.
3. LOESCHE WJ: Clinical and microbiological aspects of chcmothcrapcutic agents used according to the specific plaque hypothesis. J. Dent. Res. (1979) 58:2404-2412.
4. MOORE WEG, MOORE LVH: The bacteria of periodontal diseases. Periodontology 2000(1994) 5:66.
5. SLOTS J: Systemic antibiotics in periodontics. J. Periodontol. (1996) 67:831.
6. ZAMBON JJ: Actinobacillus aclinoinycelemoconiilans in human periodontal disease. J. Clin. Periodontol. (1985) 12:1-20.
7. DE GRAAFF J, VAN WINKLEHOFF AJ, GOENE RJ: The role of Actinobacillus actinomycetemocotntlans in periodontal disease. Infection (1989) 17:269-271.
8. SANDROSJ, PAPAPANOU PN, NANMARK U etal.-.Porpbyromonasglngtralis invades human pocket epithelium in vitro. J. Periodont. Res. (1994) 29:62-69.
9. DAHLÉN G, MANJI F, BAELUM V et al:. Putative pcriodontopathogcns in 'diseased' and 'non-diseased' persons exhibiting poor oral hygiene./ Clin. Periodontol. (1992) 19:35-42.
10. PALLASCH TJ: Pharmacokinetic principles of antimicrobial therapy. Periodontology 2000 (1996) 10:5.
11. MARIOTTI A, MONROE PJ: Pharmacologie management of periodontal diseases using systemically administered agents. Dent. Clin. North Am. (1998) 42:245.
12. BAD ERSTEN A, NILVÉUS R, EGELBERG J: Four year observations of periodontal therapy. J. Clin. Periodontol. (1987) 14:438-4444.
13. LINDHE J, WESTFELT E, NYMAN S et al:. Long-term effect of surgical/non-surgical treatment of periodontal disease./ Clin. Periodontol. (1984) 11:448-458.
14. VAN WINKELHOFF AJ, RAMS TE, SLOTS J: Systemic antibiotic therapy in periodontics. Periodontology 2000 (1996) 10:45-78.
15. WALKER C: Acquisition of antibiotic resistance in the periodontal microflora. Periodontology 2000 (1996) 10:79-88.
16. MAGNUSSON I: Local delivery of antimicrobial agents for the treatment of periodontitis. Compendium (1998) 19:953-964.
17. SOUTHARD GL, DUNN RL, GARRETT S: The drug delivery and biomaterial attributes of the Atrigcl technology in the treatment of periodontal diseases. Exp. Optn. Invest. Drugs (1998) 7:1483-1491.
18. GARRETT S, JOHNSON L, DRISKO C et al.: Two multicenter studies evaluating locally delivered doxycycline hyclatc, placebo control, oral hygiene and scaling and root planing in the treatment of periodontitis./ Periodonlol. (1999) 70:490-503.
19. STOLZE K: Concentration of mctronidazolc in periodontal pockets after application of mctronidazolc 25% dental gel. J. Clin. Periodontol. (1992) 19:698-701.
20. STOLZE K, STELLFELD M: Systemic absorption of mctronidazolc after application of mctronidazole 25% dental gel./ Clin. Periodontol. (1992) 19:693-697.
21. KNOLL-KÖHLER E: Metroidazole dental gel as an alternative to scaling and root planing in the treatment of localized adult pcriodontitis. Is its efficacy proved? Etir.J. Oral Sci. (1999) 107:415-421.
22. AINAMO J, LIE T, ELLINGSTEN BH et al.: Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis./ Clin. Periodontol. (1992) 19:723-729.
23. STELZEL M, FLORES-DE-JOCOBY L: Topical metronidazolc application compared with subgingival scaling. J. am. Periodontol. (1996) 23:24-29.
24. SOSKOLNE WA, HEASMAN PA, STABHOLZ A et ah Sustained local delivery of chlorhexidinc in the treatment of pcriodontitis: a multicentcr study. / Periodontol. (1997) 68:119-126.
25. JEFFCOAT MK, BRAY KS, CIANCIO S étal.: Adjunctive use of a subgingival controUcd-rclca.se chlorhexidinc chip reduces probing depth and improves attachment level compared with scaling and root planing alone. / Periodontol. (1998) 69:989-997.
26. LANG N: Bleeding on problhg. A predictor for the progression of periodontal disease?/ Clin. Periodontol. (1986) 13:590-596.
27. BADERSTEN A, NILVÉUS R, EGELBERG J: Effect of non-surgical periodontal therapy (VIII). Probing attachment related to clinical characteristics. / Clin. Periodontol. (1987) 14:425-432.
28. CATON JG, CIANCIO SG, BLIEDEN TM et al.: Treatment with subantimicrobial dose doxycyclinc improves the efficacy of scaling and root planing in patients with adult periodontitis./ Periodontol. (2000) 71:521-532.
29. CROUT RJ, LEE HM, SCHROEDER K et al.-. The 'cyclic' regimen of low-dose doxycycline for adult periodontitis: A preliminary study. / Periodontol. (1996) 67:506-514.
30. CATON J, CIANCIO S, CROUT R et al.: Adjunctive use of subantimicrobial doxycycline therapy for periodontitis./ Dent. Kes. (1998) 7(50:1001. 2957.
31. CATON J, BLIEDEN T, ADAMS D et ah Subantimicrobial doxycyclinc therapy for periodontitis. / Dent. Kes. (1997) 76(SI):177. 1307.
32. WALKER C: The acquisition of antibiotic resistance in the periodontal microflora. Periodontology 2000 (1996) 10:79-88.
33. WALKER C, GODOWSKI K, BORDEN L et al.: The effects of sustained release doxycycline on the anaerobic flora and antibiotic-resistant patterns in subgingival plaque and saliva./ Periodontol (2000) 71:768-774.
34. TERRANOVA V, WIKESJÖ UME: Extracellular matrices and polypeptide growth factors as mediators of functions of cells of the periodontium. J. Periodontd. (1987) 58:371-380.
35. AMERICAN ACADEMY OF PERIODONTOLOGY POSITION' PAPER: The potential role of growth and differentiation factors in periodontal regeneration./ Periodonto!. (1996) 67:545-553.
36. GREENHALGH DG, SPRUGEL KH, MURRAY MJ et al.: PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am.J.Patbol.(.1990) 136:1235-1246.
37. PIERCE GF, VANDE BERG J, RUDOLPH R et ah Plateletderived growth factor-BB and transforming growth factor beta selectively modulate glycosaminoglycans, collagen and myofibroblasts in cxcisional wounds. Am.J.Paibol.(.1991') 139:629-646.
38. SCHULTZ GS, WHITE M, MITCHELL R et al.: Epithelial wound healing enhanced by transforming growth factor-alpha and vaccinia growth factor. Science(19S7) 235:350-352.
39. LIU F, VENTURA F, DOODY J: Human Type II receptor for bone morphogcnic proteins (BMPs): extension of the two-kinase receptor mode to the BMPs. Mol. Cell Biol. (1995) 15:3-479-3486.
40. SAKAUE M, KITAZAWA S, NISHIDA K: Molecular cloning and characterization of human bone morphogcnic protein (BMP)-5 gene promoter. Biocbem. Biopbys. Res. Commun. (1996) 221:768-772.
41. FERGUSON CM, MICLAU T, HU D: The common molecular pathways in skeletal morphogenesis and repair. Ann. NYAcad. Sci. (1998) 857:33-42.
42. BOWERS G, FELTON F, MIDDLETON C et al.-. Histologie comparison of regeneration in human intrabony defects when osteogcnin is combined with demineralized frceze-dried bone allograft and with purified bovine collagen. J. Periodontol. (1991) 62:690-702.
43. MASON JM, GRANDE DA, BARCIA M: Expression of human bone morphogenic protein 7 in primary rabbit pcriosteal cells: potential utility in gene therapy for osteochondral repair. Gene Ther. (1998) 5:1098-2104.
44. RAJSHANKAR D, MCCULLOCH CA, TENENBAUM HC: Osteogenic inhibition by rat pcriodontal ligament cells: modulation of bone morphogenic protein-7 activity in vivo. Cell Tissue Res. (1998) 294:475-483.
45. HEIJL L, HEDEN G, SVÄRDSTRÖM G et al.: Enamel matrix derivative (Emdogain ) in the treatment of intrabony pcriodontal defects. J. Clin. Periodontol. (1997) 24:705-714.
46. SCULEAN A, DONOS N, WINDISCH P et al.-. Healing of human intrabony defects following treatment with enamel matrix proteins or guided tissue regeneration. J. Periodont. Res. (1999) 34:310-322.
47. PONTORIERO R, WENNSTRÖM J, LINDHE J: The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. J. Clin. Periodontol. (1999) 26:833-840.
48. MELLONIG JT: Enamel matrix derivative for periodontal reconstructive surgery: technique and clinical and histologie case report. Int.J. Periodont. Rest. Dent. (1999) 19:9-19.
49. LOESCHE WJ: The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit. Rev. Oral Bio!. Med. (1999) 10:245-275.
50. MAGNUSSON I, CLARK WB, MCARTHUR WP et al.: Treatment of subjectif with refractory pcriodontal disease./ Clin. Periodontol. (1994) 21:628-637.